About us
Between 2001 and 2003, REVEG Handels GmbH successfully introduced a Greek-designed HF pulse device onto the German-speaking market. With the production of the REHATRON™ alpha, the first HF pulse device developed by a German company, based on entirely different, cutting-edge technology and meeting the highest standards of stability and quality, we are continuing the work we began with the REHATRON™ alpha. It is our stated aim to give as many people as possible with the opportunity to receive fast and comprehensive treatment with the REHATRON™ alpha and to this end to provide doctors and healthcare professionals with a mode of therapy that has enormous potential for improving the health and quality of life of their patients.
At the same time, we continue to promote and coordinate further clinical studies in Germany, Austria and France, in order to confirm and consolidate the results obtained thus far with this method of treatment. Our research so far has shown that treatment with the REHATRON™ alpha offers a - still - rare opportunity to supplement the existing procedures and therapies, which are accepted for all general, conventional and scientific purposes, and to complement the therapeutic effects thereof.
We will be glad to receive all your questions and suggestions. Please use the contact form provided for this purpose, or simply phone.